Macrovascular complications
1 paper
- Humans1
Latest
3 in 12 monthsADA Scientific Sessions 2026 Abstract
Cardiovascular Outcomes Associated with GLP-1 Receptor Agonist Use among Adults with Type 1 Diabetes and Overweight or Obesity: A Target Trial Emulation Using Real-World EHR Data
Cohort study in peopleGLP-1 receptor agonists
ENDO 2025 Abstract
OR08-07 Real-World Evidence on GLP-1 Analogues: Insights into NAION Risk in Type 2 Diabetes Mellitus Patients
Cohort study of 381,577 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2025 Abstract
Association between the Use of Alpha-lipoic Acid and Macrovascular Complications in Patients with Diabetic Neuropathy
Cohort study of 8,740 peoplePopulations
ADA Scientific Sessions 2025 Abstract
Impact of PCSK9 Inhibitors on Carotid Plaques in Patients with Diabetes without Diagnosed ASCVD—A Retrospective Cohort Study
Cohort study in peopleType 2 diabetes
ADA Scientific Sessions 2025 Abstract
Macrovascular and Microvascular Complications in Medicare Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease From 2006–2021—Incidence Stratified by Sex, Age, and Race/Ethnicity
Cohort study in peopleAtherosclerotic cardiovascular disease
ADA Scientific Sessions 2025 Abstract
SCIP—A Novel and Efficient Screening Tool for Detecting Cognitive Impairment among Older Adults with Type 2 Diabetes
Cross-sectional study in peopleCognitive impairment
Nature Reviews Endocrinology
Cognitive function, dementia and type 2 diabetes mellitus in the elderly
ReviewMechanisms